Healers Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 26-12-2024
- Paid Up Capital ₹ 2.80 M
as on 26-12-2024
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.51 M
as on 26-12-2024
- Revenue 2.92%
(FY 2017)
- Profit 201.79%
(FY 2017)
- Ebitda 114.82%
(FY 2017)
- Net Worth 4.35%
(FY 2017)
- Total Assets 4.80%
(FY 2017)
About Healers Nutraceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.80 M.
The company currently has active open charges totaling ₹1.51 M.
Deepa Sathe, Jayabalan Victor, and Vijay Suriyanarayanan serve as directors at the Company.
- CIN/LLPIN
U24239TN1999PTC043244
- Company No.
043244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 1999
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Healers Nutraceuticals Private Limited offer?
Healers Nutraceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Healers Nutraceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepa Sathe  | Whole-Time Director | 29-Nov-2002 | Current |
| Jayabalan Victor | Director | 23-Feb-2018 | Current |
| Vijay Suriyanarayanan | Director | 23-Feb-2018 | Current |
Financial Performance of Healers Nutraceuticals.
Healers Nutraceuticals Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 2.92% increase. The company also saw a substantial improvement in profitability, with a 201.79% increase in profit. The company's net worth moved up by a moderate rise of 4.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healers Nutraceuticals?
In 2017, Healers Nutraceuticals had a promoter holding of 93.39% and a public holding of 6.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Apr 2022 | ₹1.51 M | Open |
How Many Employees Work at Healers Nutraceuticals?
Unlock and access historical data on people associated with Healers Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healers Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healers Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
